Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial.

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
22 08 2020
Historique:
entrez: 24 8 2020
pubmed: 24 8 2020
medline: 24 8 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s13063-020-04697-1 PMID: 32828129 PMC: PMC7442885
pubmed: 32828129
doi: 10.1186/s13063-020-04697-1
pii: 10.1186/s13063-020-04697-1
pmc: PMC7442885
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

733

Commentaires et corrections

Type : ErratumFor

Références

Trials. 2020 Aug 8;21(1):702
pubmed: 32771032

Auteurs

Javed Akram (J)

Vice Chancellor/Professor of Internal Medicine, University of Health Sciences, Lahore, Pakistan.

Shehnoor Azhar (S)

Assistant Professor Public Health, University of Health Sciences, Lahore, Pakistan. shehnoor.azhar@gmail.com.

Muhammad Shahzad (M)

Professor of Pharmacology, University of Health Sciences, Lahore, Pakistan.

Waqas Latif (W)

Data Analyst at University of Health Sciences, Lahore, Pakistan.

Khalid Saeed Khan (KS)

Distinguished Investigator at Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Classifications MeSH